See more : Cedergrenska AB (publ) (CEDER.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Joway Health Industries Group Inc. (GTVI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Joway Health Industries Group Inc., a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Western Forest Products Inc. (WFSTF) Income Statement Analysis – Financial Results
- Visionstate Corp. (VSSSF) Income Statement Analysis – Financial Results
- Diversicare Healthcare Services, Inc. (DVCR) Income Statement Analysis – Financial Results
- DaBomb Protein Biotech Corp. (6578.TWO) Income Statement Analysis – Financial Results
- Ekso Bionics Holdings, Inc. (EKSO) Income Statement Analysis – Financial Results
Joway Health Industries Group Inc. (GTVI)
Industry: Shell Companies
Sector: Financial Services
About Joway Health Industries Group Inc.
Joway Health Industries Group Inc. does not have significant operations. Previously, it was engaged in the manufacture and sale of tourmaline-related healthcare products. The company is based in Las Vegas, Nevada. Joway Health Industries Group Inc. is a subsidiary of JHP Holdings, Inc.
| Metric | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 609.17K | 1.67M | 3.30M | 4.28M | 3.33M | 1.70M | 1.39M | 1.90M | 4.38M | 7.51M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 295.71K | 733.16K | 1.21M | 1.55M | 1.09M | 777.75K | 546.45K | 601.03K | 1.07M | 1.89M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 313.47K | 936.16K | 2.09M | 2.73M | 2.23M | 920.34K | 844.90K | 1.30M | 3.32M | 5.63M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 51.46% | 56.08% | 63.39% | 63.85% | 67.11% | 54.20% | 60.73% | 68.33% | 75.65% | 74.90% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 74.71K | 121.79K | 222.61K | 1.60M | 1.67M | 1.58M | 1.88M | 1.52M | 2.12M | 2.07M | 2.07M | 1.76M | 74.66K | 72.91K | 46.71K |
| Selling & Marketing | 0.00 | 0.00 | 268.87K | 809.17K | 1.07M | 1.12M | 808.81K | 575.05K | 536.15K | 564.22K | 840.61K | 752.55K | 0.00 | 0.00 | 0.00 |
| SG&A | 74.71K | 121.79K | 222.61K | 2.41M | 2.74M | 2.70M | 2.69M | 2.10M | 2.65M | 2.63M | 2.91M | 2.51M | 74.66K | 72.91K | 46.71K |
| Other Expenses | 0.00 | 0.00 | -252.00 | -34.51K | -111.75K | -5.87K | -24.63K | -32.03K | -139.53K | 49.08K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 74.71K | 121.79K | 222.61K | 2.41M | 2.74M | 2.70M | 2.69M | 2.10M | 2.65M | 2.63M | 2.91M | 2.51M | 74.66K | 72.91K | 46.71K |
| Cost & Expenses | 74.71K | 121.79K | 222.61K | 3.14M | 3.95M | 4.25M | 3.79M | 2.88M | 3.20M | 3.23M | 3.97M | 4.39M | 74.66K | 72.91K | 46.71K |
| Interest Income | 0.00 | 0.00 | 166.00 | 325.00 | 727.00 | 631.00 | 664.00 | 545.00 | 865.00 | 4.13K | 6.37K | 4.24K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 325.00 | 727.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 425.85K | 447.29K | 477.12K | 486.95K | 359.68K | 507.97K | 576.62K | 508.63K | 483.98K | 346.41K | 0.00 | 0.00 | 0.00 |
| EBITDA | -74.71K | -121.79K | -222.61K | -1.01M | -169.11K | 499.35K | -84.83K | -644.94K | -943.87K | -875.30K | 506.76K | 3.47M | -74.66K | -72.91K | -46.71K |
| EBITDA Ratio | 0.00% | 0.00% | -36.54% | -60.46% | -5.12% | 11.67% | -2.55% | -37.98% | -67.84% | -46.12% | 11.56% | 46.16% | 0.00% | 0.00% | 0.00% |
| Operating Income | -74.71K | -121.79K | -222.61K | -1.49M | -666.65K | 55.37K | -454.56K | -1.17M | -1.96M | -1.33M | 410.62K | 3.12M | -74.66K | -72.91K | -46.71K |
| Operating Income Ratio | 0.00% | 0.00% | -36.54% | -89.14% | -20.20% | 1.29% | -13.67% | -68.97% | -140.55% | -70.33% | 9.37% | 41.52% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 942.81K | -34.18K | -95.88K | -5.24K | -23.96K | -31.48K | -138.67K | 53.21K | 394.21K | 2.26K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -74.71K | -121.79K | -222.86K | -1.52M | -762.53K | 50.13K | -478.52K | -1.20M | -2.09M | -1.28M | 804.83K | 3.12M | -74.66K | -72.91K | -46.71K |
| Income Before Tax Ratio | 0.00% | 0.00% | -36.58% | -91.18% | -23.10% | 1.17% | -14.39% | -70.83% | -150.52% | -67.53% | 18.36% | 41.55% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 2.10M | -33.86K | -33.00 | 916.00 | 23.77K | 3.13K | 77.42K | 17.97K | 171.10K | 507.96K | 0.00 | 0.00 | 0.00 |
| Net Income | -74.71K | -121.79K | -2.32M | -1.52M | -762.49K | 49.21K | -502.30K | -1.21M | -2.17M | -1.30M | 633.73K | 2.61M | -74.66K | -72.91K | -46.71K |
| Net Income Ratio | 0.00% | 0.00% | -381.53% | -91.18% | -23.10% | 1.15% | -15.11% | -71.01% | -156.09% | -68.48% | 14.45% | 34.79% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.01 | -0.12 | -0.08 | -0.04 | 0.00 | -0.03 | -0.06 | -0.11 | -0.06 | 0.03 | 0.14 | 0.00 | -0.02 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.12 | -0.08 | -0.04 | 0.00 | -0.03 | -0.06 | -0.11 | -0.06 | 0.03 | 0.14 | 0.00 | -0.02 | -0.01 |
| Weighted Avg Shares Out | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.03M | 20.02M | 18.89M | 18.52M | 3.76M | 3.50M |
| Weighted Avg Shares Out (Dil) | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.05M | 20.03M | 20.02M | 18.89M | 18.52M | 3.76M | 3.50M |
No news found for: GTVI
Source: https://incomestatements.info
Category: Stock Reports